Decide at what price you'd be comfortable buying and we'll help you stay ready.
L’Oréal has historically combined sustained revenue expansion with operating leverage, while maintaining positive free cash flow and moderate capital intensity. Its cash-generation capacity supports shareholder distributions alongside selective strategic investments.
The latest comparable results reinforce the established pattern of revenue growth, margin expansion, and positive free cash flow. The notable development is heavier strategic investment activity, which reduced residual cash generation without disrupting operating cash conversion.
Whether operating cash flow continues to cover capital spending after acquisition-related investment outflows normalize.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.9B | 26B | 26.9B | 29.9B | 28B | 32.3B | 38.3B | 41.2B | 43.5B | 44.1B | |
| (7.1B) | (7.4B) | (7.3B) | (8.1B) | (7.5B) | (8.4B) | (10.6B) | (10.8B) | (11.2B) | (11.3B) | |
| 17.8B | 18.7B | 19.6B | 21.8B | 20.5B | 23.9B | 27.7B | 30.4B | 32.3B | 32.7B | |
| (13.3B) | (14B) | (14.7B) | (16.3B) | (15.3B) | (17.7B) | (20.1B) | (22.7B) | (23.6B) | (23.9B) | |
| (12.5B) | (13.1B) | (13.8B) | (15.3B) | (14.3B) | (16.7B) | (19B) | (21B) | (22.2B) | (22.5B) | |
| (841.2m) | (877.1m) | (914.4m) | (985.3m) | (964.4m) | (1B) | (1.2B) | (1.3B) | (1.4B) | (1.4B) | |
| — | 100k | — | — | (100k) | (100k) | 100k | (449.9m) | 0 | (21.3m) | |
| 4.5B | 4.7B | 4.9B | 5.5B | 5.2B | 6.2B | 7.5B | 7.7B | 8.7B | 8.9B | |
| 358.1m | 353.1m | 371.4m | 316.3m | 313m | 343.3m | 377m | 356.3m | 219.5m | 149.3m | |
| 27.4m | 35.5m | 34.8m | 75.4m | 79.2m | 38m | 70.4m | 226.7m | 373.4m | 365.8m | |
| (541.3m) | (276.4m) | (94.7m) | (436.5m) | (708.9m) | (432m) | (241.5m) | — | (437.7m) | (484.1m) | |
| (25.8m) | (26.1m) | (15m) | (15.9m) | (36.5m) | (40.3m) | (72.4m) | (48.7m) | (36.7m) | (38.1m) | |
| 4.3B | 4.7B | 5.2B | 5.4B | 4.8B | 6B | 7.6B | 8B | 8.4B | 8.5B | |
| (1.2B) | (901.3m) | (1.3B) | (1.7B) | (1.2B) | (1.4B) | (1.9B) | (1.8B) | (2B) | (2.4B) | |
| 3.1B | 3.8B | 3.9B | 3.8B | 3.6B | 4.6B | 5.7B | 6.2B | 6.4B | 6.1B | |
| (2.9m) | (4.1m) | (4.1m) | (5.2m) | (4.2m) | (5.1m) | (6m) | (6.5m) | (7.8m) | (6.5m) | |
| (100k) | (100k) | 100k | 1m | 900k | 600k | 1.4m | 200k | (1.3m) | (5.5m) | |
| 3.1B | 3.6B | 3.9B | 3.8B | 3.6B | 4.6B | 5.7B | 6.2B | 6.4B | 6.1B | |
| 5.50 | 6.35 | 6.92 | 6.66 | 6.34 | 8.21 | 10.61 | 11.50 | 11.95 | 11.44 |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more